×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Liquidia Technologies, Inc. (LQDA) Reports Q1 Loss, Tops Revenue Estimates
Yahoo Movies Canada
Liquidia Technologies, Inc. (LQDA) delivered earnings and revenue surprises of 0% and 8.79%, respectively, for the quarter ended March 2023.
2 days ago
Earnings Preview: Liquidia Technologies, Inc. (LQDA) Q1 Earnings Expected to Decline
Zacks Investment Research
Liquidia Technologies (LQDA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming...
6 days ago
Courts clear FDA to OK Liquidia's dry powder PAH drug Yutrepia
Fierce Pharma
The FDA now has clearance to approve Liquidia's pulmonary arterial hypertension treatment Yutrepia after two favorable court decisions last...
1 month ago
BofA raises Liquidia Technologies stock PT to $20 on Yutrepia prospects
Investing.com
BofA raises Liquidia Technologies stock PT to $20 on Yutrepia prospects ... © Reuters. ... On Thursday, BofA Securities adjusted its outlook on...
1 month ago
Earnings Preview: Liquidia Technologies, Inc. (LQDA) Q1 Earnings Expected to Decline
Yahoo Finance
Liquidia Technologies (LQDA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming...
6 days ago
Why Is Pulmonary Hypertension-Focused Liquidia Stock Soaring Today?
markets.businessinsider.com
Liquidia Corp (NASDAQ:LQDA) stock jumped after a win in a patent dispute with United Therapeutics Corporation (NASDAQ:UTH...
4 months ago
Liquidia Technologies Sees Patent Claims Dismissed by United Therapeutics - TipRanks.com
Tipranks
Liquidia Technologies Inc (LQDA) has released an update. Liquidia Corporation reported that United Therapeutics dismissed all claims...
3 months ago
Liquidia Corporation Provides Update on New Drug Application for YUTREPIA™ (treprostinil) inhalation powder
GlobeNewswire
MORRISVILLE, N.C., Jan. 25, 2024 (GLOBE NEWSWIRE) -- Liquidia Corporation (the Company) (NASDAQ: LQDA) announced today that the U.S. Food...
3 months ago
Liquidia Urges SCOTUS to Restore Preclusive Effect to PTAB Final Written Decisions
IPWatchdog.com
Last week, biopharmaceutical company Liquidia Technologies filed a petition for writ of certiorari with the U.S. Supreme Court to appeal a...
3 months ago
FDA faces lawsuit from United on its Liquidia NDA process
Fierce Pharma
United is challenging the FDA, questioning the thoroughness of its approval process for Liquidia's Yutrepia, a competitor to United Tyvaso.
2 months ago